(NASDAQ:RXST) LOS ANGELES, Sept. 2, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against RxSight, Inc. ("RxSight" or "the Company") (NASDAQ: RXST) for violations of §§10(b) and 20(a) of the Securities Exchange Act...
Related Questions
How likely is the lawsuit to result in a material settlement or judgment that could affect RXST's market valuation?
What are the potential short‑term price movements for RXST based on the timing of any court rulings or disclosures related to the case?
How might this securities fraud claim influence investor sentiment and liquidity for RXST compared to its peers in the ophthalmic device sector?